fingolimod has been researched along with siponimod in 4 studies
| Studies (fingolimod) | Trials (fingolimod) | Recent Studies (post-2010) (fingolimod) | Studies (siponimod) | Trials (siponimod) | Recent Studies (post-2010) (siponimod) |
|---|---|---|---|---|---|
| 65 | 0 | 51 | 127 | 20 | 124 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guerrero, M; Roberts, E; Rosen, H; Urbano, M | 1 |
| Balimane, P; Barrish, JC; Carter, PH; Cornelius, G; Cvijic, ME; D'Arienzo, CJ; Dabros, M; Dhar, TG; Dyckman, AJ; Heimrich, EM; Hennan, J; Lehman-McKeeman, LD; Levesque, PC; Marino, AM; Mathur, A; McIntyre, KW; Salter-Cid, L; Shen, DR; Shi, H; Taylor, TL; Thomas, R; Warrack, B; Wu, DR; Xiao, HY; Xie, J; Yang, X; Yang, Z; Zhou, XD; Zhu, JL | 1 |
| Dyckman, AJ | 1 |
| Camp, SM; Garcia, JGN; Marciniak, A; Polt, R | 1 |
3 review(s) available for fingolimod and siponimod
| Article | Year |
|---|---|
Modulators of the Sphingosine 1-phosphate receptor 1.
Topics: Animals; Humans; Immunosuppressive Agents; Receptors, Lysosphingolipid; Signal Transduction; Structure-Activity Relationship | 2013 |
Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P
Topics: Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Humans; Ligands; Lysophospholipids; Molecular Structure; Receptors, Lysosphingolipid; Sphingosine; Structure-Activity Relationship | 2017 |
An update on sphingosine-1-phosphate receptor 1 modulators.
Topics: Autoimmune Diseases; Biological Availability; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis; Oxadiazoles; Receptors, Lysosphingolipid; Sphingolipids | 2018 |
1 other study(ies) available for fingolimod and siponimod
| Article | Year |
|---|---|
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials.
Topics: | 2016 |